Journal of Neuroscience · 2011 · 148 citations · 19 references
Life SciencesNeurologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersNeurological Disease ModelsParkinson DiseaseParkinsonian DisordersAdenoviral VectorsDopaminergic NeurodegenerationDopaminergic NeuronsLrrk2 MutationsNeurodegeneration ModelsParkinson's Disease ModelsParkinsonian DegenerationRodent Neurodegeneration
The G2019S mutation in the leucine-rich repeat kinase 2 (LRRK2) gene is the most common genetic cause of Parkinson's disease (PD), accounting for a significant proportion of both autosomal dominant familial and sporadic PD cases. Our aim in the present study is to generate a mammalian model of mutant G2019S LRRK2 pathogenesis, which reproduces the robust nigral neurodegeneration characteristic of PD. We developed adenoviral vectors to drive neuron-specific expression of full-length wild-type or mutant G2019S human LRRK2 in the nigrostriatal system of adult rats. Wild-type LRRK2 did not induce any significant neuronal loss. In contrast, under the same conditions and levels of expression, G2019S mutant LRRK2 causes a progressive degeneration of nigral dopaminergic neurons. Our data provide a novel rat model of PD, based on a prevalent genetic cause, that reproduces a cardinal feature of the disease within a rapid time frame suitable for testing of neuroprotective strategies.
19
A common LRRK2 mutation in idiopathic Parkinson's disease
William P. Gilks, Patrick M. Abou‐Sleiman, Sonia Gandhi et al. · The Lancet · 2005 · 778 citations · Full text
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li, Wencheng Liu, Tinmarla F. Oo et al. · Nature Neuroscience · 2009 · 540 citations · Full text
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup, Darren J. Moore, Fulvio Celsi et al. · Annals of Neurology · 2006 · 515 citations